December 1, 2023

December 2023 Provider Newsletter

Contents

AdministrativeMedicare AdvantageNovember 1, 2023

Updates to correct coding editing

AdministrativeCommercialDecember 1, 2023

New vendor administering Primary Care Access Survey

AdministrativeCommercialDecember 1, 2023

New vendor administering behavioral health access survey

AdministrativeCommercialDecember 1, 2023

Outpatient system updates for 2024

AdministrativeCommercialDecember 1, 2023

Professional system updates for 2024

AdministrativeCommercialDecember 1, 2023

Important information about Utilization Management

AdministrativeCommercialMedicare AdvantageMedicaidDecember 1, 2023

New requirements for credentialing and recredentialing

AdministrativeCommercialDecember 1, 2023

Case Management Program

AdministrativeCommercialDecember 1, 2023

Coordination of care

AdministrativeCommercialDecember 1, 2023

CAA: Review your online provider directory information

AdministrativeCommercialDecember 1, 2023

Clinical practice and preventive health guidelines

AdministrativeCommercialDecember 1, 2023

Members’ Rights and Responsibilities

Digital SolutionsCommercialDecember 1, 2023

Clinical Documentation Lookup Tool

Digital SolutionsMedicaidDecember 1, 2023

Filing digital claims disputes: Transparent and trackable

Education & TrainingMedicare AdvantageDecember 1, 2023

Model of care training reminder

Policy UpdatesCommercialDecember 1, 2023

Medical Policy and Clinical UM Guidelines notification

Medical Policy & Clinical GuidelinesMedicaidNovember 21, 2023

Medical Policies and Clinical Utilization Management Guidelines update for May 2023

Medical Policy & Clinical GuidelinesMedicare AdvantageNovember 21, 2023

Medical Policies and Clinical Utilization Management Guidelines update for May 2023

Medical Policy & Clinical GuidelinesMedicare AdvantageDecember 1, 2023

Glucagon-Like Peptide-1 prior authorization changes

Medical Policy & Clinical GuidelinesMedicaidNovember 7, 2023

Carelon Medical Benefits Management, Inc. updates

Medical Policy & Clinical GuidelinesMedicare AdvantageNovember 6, 2023

Carelon Medical Benefits Management, Inc. updates

Medical Policy & Clinical GuidelinesCommercialOctober 27, 2023

Transition to Carelon Medical Benefits Management, Inc. Genetic Testing Guidelines

Medical Policy & Clinical GuidelinesMedicaidOctober 27, 2023

InterQual 2023 - October updates

Prior AuthorizationMedicare AdvantageNovember 15, 2023

Prior authorization requirement changes effective May 1, 2024 

Prior AuthorizationMedicare AdvantageNovember 15, 2023

Prior authorization requirement changes effective May 1, 2024 

Prior AuthorizationMedicare AdvantageNovember 9, 2023

Prior authorization requirement changes effective March 1, 2024 

Prior AuthorizationMedicare AdvantageNovember 8, 2023

Prior authorization requirement changes effective May 1, 2024 

Prior AuthorizationMedicare AdvantageOctober 31, 2023

Prior authorization requirement changes effective March 1, 2024 

Products & ProgramsCommercialDecember 1, 2023

Introducing the High Performing Provider designation

Federal Employee Program (FEP)CommercialDecember 1, 2023

Federal Employee Program updates member ID cards

Federal Employee Program (FEP)Medicare AdvantageDecember 1, 2023

2024 Federal Employee Program Benefit information available online

PharmacyCommercialNovember 1, 2023

Pharmacy information available on our provider website

PharmacyMedicare AdvantageOctober 26, 2023

Notification of specialty pharmacy medical step therapy updates

Quality ManagementMedicaidNovember 20, 2023

HEDIS measurement year 2023 documentation for Transitions of Care (TRC)

Quality ManagementMedicaidNovember 13, 2023

HEDIS 2023 Electronic Clinical Data Systems (ECDS)

Quality ManagementCommercialMedicare AdvantageNovember 13, 2023

HEDIS 2023 Electronic Clinical Data Systems (ECDS)

NVBCBS-CDCRCM-045274-23

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

AdministrativeMedicare AdvantageNovember 1, 2023

Updates to correct coding editing

Effective for claims processed on or after December 1, 2023, the editing systems at Anthem Blue Cross and Blue Shield will be updated to align with the American Medical Association (AMA) CPT® Manual, HPCPS Level II Manual, and Centers for Medicare & Medicaid Services (CMS) correct coding guidelines, for the following services:

  • Ulcer debridement and ulcer staging:

    • According to the ICD-10 Diagnosis Coding Manual, specific diagnosis codes that reflect the stage of the ulcer should be billed with the appropriate CPT code. For example, if billing a stage 3 pressure ulcer code, a stage 4 diagnosis code should not be reported.
    • According to the AMA CPT Manual, a debridement of an ulcer should be reported with the appropriate diagnosis code that reflects that service.
  • Billing of anatomical modifiers:

    • According to the AMA CPT and HCPCS Level II manuals, the appropriate anatomical modifier is required to be appended to the appropriate procedure code. If not, the claim line will be denied. These modifiers designate the body part that a service is being performed on (for example, FA: Left hand, thumb, TA: Left foot, great toe).
  • Billing of interprofessional telephone/internet consultations:

    • These billed procedure codes will follow the AMA CPT Manual coding guidelines.

Claim lines not billed in accordance with the correct coding guidance outlined above will be denied.

If you disagree with a claim reimbursement decision, please follow the claim dispute process (including submission of such documentation with the dispute) as outlined in the Provider Manual.

If you have questions about this communication or need assistance with any other item, contact your provider relationship management representative.

With your help, we can continually build towards a future of shared success.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-038660-23, MULTI-BCBS-CR-046278-23-CPN45683

AdministrativeCommercialDecember 1, 2023

New vendor administering Primary Care Access Survey

In 2024, the annual PCP Access Studies Office Level Survey will be performed by a new vendor, the Center for the Study of Services (CSS). The purpose of this survey is to assess adequate appointment wait times for our members with an urgent condition or for routine services. The survey will be conducted in the same manner as in the past, and your cooperation is expected and appreciated. Kindly notify office staff of the requirement to participate in this survey.

Keeping your data up to date is a condition of your provider contract with Anthem Blue Cross and Blue Shield (Anthem) and a requirement as part of the Consolidated Appropriations Act (CAA). We ask that you update office information using the PDM application on the Availity Essentials platform and that you participate in quality programs such as this critical survey.

Office information crucial for the survey includes:

  • Having correct, working phone numbers.
  • Updating information such as when a practitioner has moved, retired, or is deceased.
  • Updating if your practice is no longer contracted with Anthem, accepts private pay only, or is no longer in business.

You are also required to provide compliant after-hours, 24/7, urgent care messaging, instructing the caller/patient to hang up and call 911 or go to urgent care or emergency room (ER) or you must directly connect the caller with PCP or on-call physician.

Your contract compels access for all covered members to obtain timely needed appointments. The leading timeframes are below.

Nevada

Primary care appointment access

Urgent appointment

Within 24 hours

Routine appointment

Within 10 business days

Routine physical appointment

Within 30 days

Routine/follow-up appointment

Evaluate progress from today’s visit

Within 30 calendar days

Preventive care appointment

Within 30 calendar days

See your Anthem Blue Cross and Blue Shield Provider Manual for details


Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CM-044763-23-CPN44728

AdministrativeCommercialDecember 1, 2023

New vendor administering behavioral health access survey

The annual behavioral health access studies will see a change in 2024 as a new vendor, Center for the Study of Services (CSS) in Washington, D.C., will be performing the office level survey and making calls during the first through third quarters. The survey will be conducted in the same manner as in the past and your cooperation is expected and appreciated. The purpose is to assess adequate appointment wait times for our members with an urgent condition or for routine services.

Consequently, we ask that you update office information using the PDM application on Availity Essentials or follow processes if assigned to Carelon Behavioral Health, Inc., and that you participate in quality programs, such as this critical survey, as a condition of your contract. The main challenges the vendor encounters are incorrect or non-working phone numbers; practitioner moved, retired, or is deceased; the practice has left their Anthem Blue Cross and Blue Shield (Anthem) contract, accepts private pay only, or is no longer in practice; and staff refusing to participate in the survey. Please take time to update information for each practitioner associated with the practice phone number(s), past or present.

Your contract compels access for all covered individuals to obtain timely needed appointments. The leading timeframes are below. See your Anthem Provider Manual for details. And don’t forget your compliant after-hours emergency or urgent messaging 24/7, by a recording or a live person, instructing the caller/patient to hang up and call 911 or 24-hour crisis services, or go to urgent care or ER; or directly connecting with practitioner or on-call practitioner.

Nevada behavioral healthcare appointment access

Emergent — non-life threatening

Within six hours

Urgent appointment

Within 24 hours

Discharge follow-up BH appointment (new or existing patient)

Within seven calendar days

Routine — initial appointment (new patient)

Within 10 business days

Routine — regular appointment

Within 10 business days

Routine — follow-up appointment (evaluate progress from today’s visit)

Within 30 calendar days

We are committed to helping patients more easily access the care they need.

Carelon Behavioral Health, Inc. is an independent company providing utilization management services on behalf of the health plan.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CM-044749-23-CPN44731

AdministrativeCommercialDecember 1, 2023

Outpatient system updates for 2024

As a reminder, we will update our claim editing software for outpatient facility services throughout 2024, with many updates occurring quarterly. These updates include, but are not limited to:

  • The addition of new and revised codes (for example, CPT®, HCPCS, ICD-10, modifiers, revenue codes) and associated edits.
  • Updates related to the appropriate use of various code combinations, including but not limited to, CPT/HCPCS code to revenue code, type of bill to procedure code, type of bill to CPT/HCPCS code, and CPT/HCPCS code to modifier.
  • Updates to National Correct Coding Initiative edits (NCCI) and facility outpatient hospital services medically unlikely edits (MUEs).
  • Updates to reflect coding requirements as designated by industry standard sources such as the National Uniform Billing Committee (NUBC) and the Centers for Medicare and Medicaid Services (CMS).

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-044221-23-CPN44078

AdministrativeCommercialDecember 1, 2023

Professional system updates for 2024

As a reminder, we will update our claim editing software for professional services throughout 2024, with most updates occurring quarterly. These updates apply to any provider, provider group (identified by tax identification number), and/or across providers and claim type (such as, professional or facility) and include, but are not limited to:

  • The addition of new, and revised codes (for example, CPT®, HCPCS, ICD-10, modifiers) and associated edits such as:
    • ICD-10 laterality
    • Add-on procedures (indicated by + sign)
    • Code book parenthetical statements and other directives about appropriate code use (for example, separate procedure, do not report, list separately in addition to, etc.)
  • Updates to editing for multiple procedure and bilateral reduction calculations based on relative value unit (RVU) as designated and updated by the Centers for Medicare & Medicaid (CMS) in the physician fee schedule relative value (PFSRV) files
  • Updates to National Correct Coding Initiative edits (NCCI) and medically unlikely edits (MUEs)
  • Updates to incidental, mutually exclusive, and unbundled (re-bundle) edits
  • Updates to code edits associated with reimbursement policies including, but not limited to, bundled services, global surgery preoperative, and post-operative periods assigned by CMS, edits that allow/disallow for assistant surgeon/co-surgeon/team surgeon, and frequency edits.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-044218-23-CPN44074

AdministrativeCommercialDecember 1, 2023

Important information about Utilization Management

Our utilization management (UM) decisions are based on the appropriateness of care and service needed, as well as the member’s coverage according to their health plan. We do not reward providers or other individuals for issuing denials of coverage, service, or care. Nor, do we make decisions about hiring, promoting, or terminating these individuals based on the idea or thought that they will deny benefits. In addition, we do not offer financial incentives for UM decision makers to encourage decisions resulting in under-utilization. Anthem Blue Cross and Blue Shield’s (Anthem) medical policies are available on Anthem’s website at Anthem.com.

Refer to attachment to view full details

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CM-044481-23-CPN44383

ATTACHMENTS (available on web): Important information about Utilization Management (pdf - 0.1mb)

AdministrativeCommercialMedicare AdvantageMedicaidDecember 1, 2023

New requirements for credentialing and recredentialing

The National Committee on Quality Assurance (NCQA) has advised Durable Medical Equipment (DME) providers are to be considered within the scope of an entity’s credentialing program for accreditation purposes. Starting February 2024, recredentialing of the existing Durable Medical Equipment Providers and Prosthetic and Orthotic Suppliers (DMEPOS) network will begin. You will receive communication asking you to either complete an application or to supply us with any of the following information:

  • Copy of all federal, state, and/or local licenses required to operate as a healthcare facility (by location).
  • Copy of accreditation certificate or letters if accredited.
  • Copy of most recent CMS or state survey (with deficiencies) including cover letter from CMS or state agency stating facility is in substantial compliance or Corrective Action Plan if deficiencies were cited if not accredited is required.

Please respond to these communications as quickly as possible so no disruption in service to our members or to you occurs. Contact information for questions related to this change will be included in the outreach sent.

Through genuine collaboration, we can simplify access to care and help you deliver high-quality, equitable healthcare. The Credentialing team looks forward to working with you.

What if I need assistance?

If you have questions about this communication or need assistance with any other item, contact your local Provider Relationship Management representative or call Provider Services at 844-396-2330 for Medicaid and for Commercial and Medicare Advantage refer providers to the number on the back of their patient’s member ID card.

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CDCRCM-041411-23-CPN39398

AdministrativeCommercialDecember 1, 2023

Case Management Program

Managing any illness can be a difficult thing to do. Knowing who to contact, what test results mean, or how to get needed resources is very important and can be overwhelming.

Anthem Blue Cross and Blue Shield (Anthem) is available to help with our Case Management Program. Our case managers are part of an interdisciplinary team of clinicians and professionals that are there to support members, families, primary care physicians, behavioral health (BH) practitioners, and caregivers. The case management process uses the experience and expertise of the care coordination team whose goal is to educate and empower our members to increase self-management skills, understand their illness, and learn about care choices in order to access quality, efficient healthcare.

For physical health services, members or caregivers can refer themselves or family members by calling the number located below. They will be transferred to a team member based on the immediate need. Physicians can also refer their patients by contacting us telephonically or through electronic means. No issue is too big or too small. We can help with transitions across level of care so that patients and caregivers are better prepared and informed about healthcare decisions and goals.

For BH or substance use disorder services members can contact their health plan to verify benefits and access Anthem.com, or if an FEP member, fepblue.com to search for and access BH providers. It is best to have the member or member’s family contact our department directly to ensure privacy.

How do you contact us?

For commercial and exchange members, the member can contact customer service for assistance.

For FEP members, physical and behavioral health practitioners can refer to Anthem behavioral health case management with member consent by calling 800-711-2225 option 3.

Email address (if available)

Phone number

Business hours

Colorado, Nevada

Care.management@anthem.com

Phone: 888-613-1130

Monday-Friday, 8 a.m.–7 p.m. MT

National

Care.management@anthem.com

Phone: 877-783-2756

Transplant Phone: 866-536-9897 x1664030784

Fax: 888-438-7051

Monday-Friday, 8 a.m.-9 p.m. PT,

Saturday 9 a.m.-4:30 p.m. PT

Monday-Friday 8:30 a.m.-5 p.m. ET (Transplant)

FEP

FEP.Care.Coordination@anthem.com

Phone: 800-711-2225

Monday-Friday, 9 a.m.-6 p.m. ET

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-044863-23-CPN444375

AdministrativeCommercialDecember 1, 2023

Coordination of care

Coordination of care among providers is a vital aspect of good treatment planning to ensure appropriate diagnosis, treatment, and referral. Anthem Blue Cross and Blue Shield (Anthem) would like to take this opportunity to stress the importance of communicating with your patient’s other healthcare practitioners. This includes primary care physicians (PCPs) and medical specialists, as well as behavioral health practitioners (BH).

Coordination of care is especially important for patients with high utilization of general medical services and those referred to a BH specialist by another healthcare practitioner. Anthem urges all of its practitioners to obtain the appropriate permission from these patients to coordinate care between BH and other healthcare practitioners at the time treatment begins. We expect all healthcare practitioners to:

  • Discuss with the patient the importance of communicating with other treating practitioners.
  • Obtain a signed release from the patient and file a copy in the medical record:
    • Document in the medical record if the patient refuses to sign a release.
  • Document in the medical record if you request a consultation.
  • If you make a referral, transmit necessary information; and if you are furnishing a referral, report appropriate information back to the referring practitioner.
  • Document evidence of clinical feedback (in other words, consultation report) that includes, but is not limited to:
    • Diagnosis
    • Treatment plan
    • Referrals
    • Psychopharmacological medication (as applicable)

To facilitate coordination of care, we have several tools available on our Provider website for BH and other medical practitioners including:

  • Coordination of Care Form
  • Coordination of Care Letter Template - Behavioral Health
  • Coordination of Care Letter Template - Medical

The following behavioral health forms, brochures, and screening tools for substance use and attention-deficit/hyperactivity disorder (ADHD) are also available on our Provider website:

  • Alcohol Use Assessment Brochure
  • Antidepressant Medication Management
  • Edinburgh Postnatal Depression Scale
  • Opioid Use Assessment Brochure
  • Substance Brief Intervention/Referral Tool (SBIRT)
  • Vanderbilt ADHD Diagnostic Parent Rating Scale

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-044475-23-CPN44372

AdministrativeCommercialDecember 1, 2023

CAA: Review your online provider directory information

We ask that you review your online provider directory information on a regular basis to ensure it is accurate. Access your information by visiting anthem.com/provider, then select the Find Care button at the top right of the webpage.

Submit updates and corrections to your directory information by following the instructions on our Provider Maintenance webpage. We will send you an email acknowledging receipt of your request. Online update options include:

  • Add/change an address location
  • Name change
  • Phone/fax number change
  • Provider leaving a group or a single location
  • Closing a practice location

The Consolidated Appropriations Act (CAA) of 2021 contains a provision that requires online provider directory information be reviewed and updated as needed at least every 90 days. Reviewing your information on a regular basis is the best way to help ensure your online provider directory information is current.

With your help, we can continually build towards a future of shared success.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-044661-23-CPN44642

AdministrativeCommercialDecember 1, 2023

Clinical practice and preventive health guidelines

As part of our commitment to provide you with the latest clinical information and educational materials, we have adopted nationally recognized medical, behavioral health and preventive health guidelines, which are available to providers on our website. The guidelines, which are used for our quality programs, are based on reasonable medical evidence, and are reviewed for content accuracy, current primary sources, the newest technological advances, and recent medical research.

All guidelines are reviewed annually and updated as needed. The current guidelines are available on our website at https://www.anthem.com/provider/ and select Change State >Provider > Select Policies, Guidelines & Manuals under Provider Resources> scroll down and select Clinical Practice Guidelines or Preventive Health Guidelines.

If you have questions, please contact the number on the back of the member ID card for Provider Services.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-044458-23-CPN44378

AdministrativeCommercialDecember 1, 2023

Members’ Rights and Responsibilities

The delivery of quality healthcare requires cooperation between patients, their providers, and their healthcare benefit plans. One of the first steps is for patients and providers to understand their rights and responsibilities. Therefore, in line with our commitment to involve the health plan, participating practitioners, and members in our system, Anthem Blue Cross and Blue Shield has adopted a Members’ Rights and Responsibilities statement.

This statement can be found on our website under the FAQ question about Laws and Rights that Protect You. To access the statement, visit anthem.com and select Provider. From there, select Policies, Guidelines & Manuals under Provider Resources. Select your state and scroll down to Member Rights and Responsibilities under More Resources. Then select the Read about member rights link. For federal employees, practitioners may access the FEP member portal at www.fepblue.org/memberrights to view the FEPDO Member Rights Statement.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-044468-23-CPN44377

Digital SolutionsCommercialDecember 1, 2023

Clinical Documentation Lookup Tool

A new way to review Medical Policies and Utilization Management (UM) Guidelines for needed documentation

Using Medical Policies and UM Guidelines, we’ve developed a tool that supplies you with a list of recommended documents when submitting prior authorizations or claims. The new Clinical Documentation Lookup Tool uses the CPT® and HCPCS codes you enter to return real-time results.

Accessing the tool is easy, too — either by visiting our provider website (access the Clinical Documentation Lookup Tool from our Policies, Guidelines & Manuals section) or through Payer Spaces on Availity.com. For direct access, use this address (available mid-December) https://clinicaldocumentationtool.anthem.com/cdltui/home.

Start by entering in the member’s plan type, state, and service dates. Enter the Procedure Code or use the Keyword Search box. The recommended documents will be returned along with a full copy of the Medical Policy.

The Clinical Documentation Lookup Tool was developed to be intuitive and easy to use, but we’ve created a demonstration that points out some helpful tips. Access the demo from the top right navigation bar on the Clinical Documentation Lookup Tool.

The new Clinical Documentation Lookup Tool will be available in December. Try it and tell us what you think by completing the Was this tool helpful? question.

We are focused on reducing administrative burdens, so you can do what you do best — care for our members.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-045315-23-CPN44857

Digital SolutionsMedicaidDecember 1, 2023

Filing digital claims disputes: Transparent and trackable

When you have more information to share about a claim that has been denied, filing the dispute digitally is a cost-effective and time-saving alternative to paper and fax. You can feel confident that we have received your claims dispute when you submit it through the digital workflow.

This Claim Status application feature, available on Availity.com, enables a fast, efficient, and streamlined process for filing claim disputes:

  • Upload supporting documentation and attach it directly to the claim.
  • Use the Appeals Dashboard:
    1. To review digitally filed disputes.
    2. To retrieve correspondence related to your disputes.
    3. For a history of digitally filed disputes.

How to file a digital claim payment dispute:

    1. Log onto Availity.com.
    2. Select the Claims & Payments tab.
    3. Select Claim Status and enter the information needed to retrieve your claim.
    4. When you have found your claim, select the Dispute button to initiate a dispute (it will be visible when your claim is eligible for a dispute).
    5. Access your Appeals Dashboard to upload the supporting documents, locate initiated dispute, and complete the dispute request:
      • From the Claims & Payments tab select Appeals to access your Appeals Dashboard.

In the past, you may have used the Attachment button and selected the Dispute option to dispute a claim. We’ve eliminated that process to make disputing a claim more trackable and transparent.

Receive dispute determinations digitally from your Appeals Dashboard

We will review the dispute and communicate an outcome on Availity.com. Check the status of a digitally submitted dispute at any time from your Appeals Dashboard.

Learn more

Submitting a digital claim payment dispute is easy, but attending informative learning sessions provides a deep dive into the application and its search and filter functions. These tips are sure to make the submission process even easier.

Use this link to access on-demand training.

For more information about the claim payment dispute process, consult the provider manual or reach out to your provider relationship management representative.

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CD-041332-23-CPN41106

Education & TrainingMedicare AdvantageDecember 1, 2023

Model of care training reminder

As a contracted provider for special needs plan (SNP) from Anthem Blue Cross (Anthem), you are required to participate in an annual model of care training for providers per CMS regulations. This training includes a detailed overview of Anthem special needs plans and program information — highlighting cost sharing, data sharing, participation in the Interdisciplinary Care team (ICT), where to access the member’s health risk assessment results, plan of care, and benefit coordination. Please remember this training is specific to our plans and delivery of care for members ensuring their specific care needs are met. Your participation is critical for improved quality and health outcomes.

Training for SNP product for Anthem is self-paced and available at availity.com.

The training must be completed by December 31, 2023.

How to access the Custom Learning Center on the Availity Essentials website:

  1. Log in to Availity Essentials website at availity.com:
    • At the top of Availity Essentials website, select Payer Spaces and select the appropriate payer.
  2. On the Payer Spaces landing page, select Access Your Custom Learning Center from Applications.
  3. In the Custom Learning Center, select Required Training.
  4. Select Special Needs Plan and Model of Care Overview.
  5. Select Enroll.
  6. Select Start.
  7. Once the course is completed, select Begin Attestation and complete.

Not registered for Availity Essentials?

Have your organization’s designated administrator register your organization for the Availity Essentials website:

  1. Visit availity.com to register.
  2. Select Register.
  3. Select your organization type.
  4. In the Registration wizard, follow the prompts to complete the registration for your organization.

Refer to these PDF documents: https://apps.availity.com/availity/Demos/Registration/index.htm for complete registration instructions.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-044322-23-CPN44315

Policy UpdatesCommercialDecember 1, 2023

Medical Policy and Clinical UM Guidelines notification

Anthem Blue Cross and Blue Shield (Anthem) and our subsidiary company, HMO Nevada, are pleased to provide you with our updated and new Medical Policies. Anthem will also be implementing changes to our Clinical Utilization Management (UM) Guidelines that are adopted for Nevada. The Clinical UM Guidelines published on our website represent the Clinical UM Guidelines currently available to all plans for adoption throughout our organization. Because local practice patterns, claims systems and benefit designs vary, a local plan may choose whether to implement a particular Clinical UM Guideline. The link below can be used to confirm whether the local Plan has adopted the Clinical UM Guideline(s) in question. Adoption lists are created and maintained solely by each local plan.

The major new policies and changes are summarized below. Please refer to the specific policy for coding, language, and rationale updates and changes that are not summarized in the attachment.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CM-044648-23

ATTACHMENTS (available on web): Medical Policy and Clinical UM Guidelines notification (MAC) (pdf - 0.21mb)

Medical Policy & Clinical GuidelinesMedicaidNovember 21, 2023

Medical Policies and Clinical Utilization Management Guidelines update for May 2023

The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised to support clinical coding edits. Note, several policies and guidelines were revised to provide clarification only and are not included. Existing precertification requirements have not changed.

Please share this notice with other providers in your practice and office staff.

To view a guideline, visit anthem.com/provider/policies/clinical-guidelines/search.

Notes/Updates:

Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive.

  • MED.00004 – Noninvasive Imaging Technologies for the Evaluation of Skin Lesions; Previously Titled: Technologies for the Evaluation of Skin Lesions (including Dermatoscopy, Epiluminescence Microscopy, Videomicroscopy and Ultrasonography)
    • Revised title
    • Added additional technologies to Investigational & Not Medically Necessary section
  • SURG.00161 – Nanoparticle-Mediated Thermal Ablation
    • Nanoparticle-mediated thermal ablation is considered Investigational & Not Medically Necessary for all indications
  • CG-ANC-06 – Ambulance Services: Ground; Non-Emergent
    • Revised Medically Necessary and Not Medically Necessary statements regarding mileage
    • Revised Not Medically Necessary statement to remove list of non-covered indications
  • CG-LAB-29 – Gamma Glutamyl Transferase Testing
    • Outlines the Medically Necessary and Not Medically Necessary criteria for laboratory testing of gamma glutamyl transferase (GGT) in blood
  • CG-LAB-30 – Outpatient Laboratory-based Blood Glucose Testing
    • Outlines the Medically Necessary and Not Medically Necessary criteria for laboratory testing to determine blood glucose concentration
  • CG-SURG-95 – Sacral Nerve Stimulation and Percutaneous or Implantable Tibial Nerve Stimulation for Urinary and Fecal Incontinence; Urinary Retention; Previously Titled: Sacral Nerve Stimulation and Percutaneous Tibial Nerve Stimulation for Urinary and Fecal Incontinence, Urinary Retention
    • Revised title
    • Added Medically Necessary criteria for temporary SNS for urinary and fecal conditions
    • Reformatted Medically Necessary criteria for permanent SNS for urinary and fecal conditions
    • Revised the Clinical Indications section IV for percutaneous or implantable tibial nerve stimulation (PTNS) to include implantable devices

Medical Policies

On May 11, 2023, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem Blue Cross and Blue Shield Healthcare Solutions (Anthem). These medical policies take effect January 1, 2024.

Publish Date

Medical Policy Number

Medical Policy Title

New or Revised

5/25/2023

GENE.00052

Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling

Revised

6/28/2023

*MED.00004

Noninvasive Imaging Technologies for the Evaluation of Skin Lesions Previously Titled: Technologies for the Evaluation of Skin Lesions (including Dermatoscopy, Epiluminescence Microscopy, Videomicroscopy and Ultrasonography)

Revised

7/18/2023

MED.00135

Gene Therapy for Hemophilia

Revised

5/25/2023

SURG.00121

Transcatheter Heart Valve Procedures

Revised

6/28/2023

*SURG.00161

Nanoparticle-Mediated Thermal Ablation

New

6/28/2023

TRANS.00025

Laboratory Testing as an Aid in the Diagnosis of Heart Transplant Rejection

Revised

Clinical UM Guidelines

On May 11, 2023, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Medicaid members on June 22, 2023. These guidelines take effect January 1, 2024.

Publish Date

Clinical UM Guideline Number

Clinical UM Guideline Title

New or Revised

6/28/2023

*CG-ANC-06

Ambulance Services: Ground; Non-Emergent

Revised

6/28/2023

CG-DME-31

Powered Wheeled Mobility Devices

Revised

6/28/2023

CG-DME-36

Pediatric Gait Trainers

Revised

6/28/2023

CG-DME-42

Continuous Glucose Monitoring Devices and External Insulin Infusion Pumps

Revised

6/28/2023

CG-GENE-16

BRCA Genetic Testing

Revised

6/28/2023

CG-GENE-22

Gene Expression Profiling for Managing Breast Cancer Treatment

Revised

5/25/2023

CG-LAB-22

Nucleic Acid Amplification Tests Using Algorithmic Analysis for the Diagnosis of Vaginitis Previously Titled: Nucleic Acid Amplification Tests Using Algorithmic Analysis for the Diagnosis of Bacterial Vaginosis

Revised

6/28/2023

CG-LAB-25

Outpatient Glycated Hemoglobin and Protein Testing

Revised

6/28/2023

*CG-LAB-29

Gamma Glutamyl Transferase Testing

New

6/28/2023

*CG-LAB-30

Outpatient Laboratory-based Blood Glucose Testing

New

6/28/2023

CG-MED-59

Upper Gastrointestinal Endoscopy in Adults

Revised

6/28/2023

CG-MED-66

Cryopreservation of Oocytes or Ovarian Tissue

Revised

6/28/2023

CG-SURG-101

Ablative Techniques as a Treatment for Barrett's Esophagus

Revised

5/25/2023

CG-SURG-115

Mechanical Embolectomy for Treatment of Stroke

Revised

6/28/2023

CG-SURG-61

Cryosurgical, Radiofrequency or Laser Ablation to Treat Solid Tumors Outside the Liver

Revised

6/28/2023

CG-SURG-78

Locoregional Techniques for Treating Primary and Metastatic Liver Malignancies Previously Titled: Locoregional and Surgical Techniques for Treating Primary and Metastatic Liver Malignancies

Revised

6/22/2023

CG-SURG-81

Cochlear Implants and Auditory Brainstem Implants

Revised

6/28/2023

*CG-SURG-95

Sacral Nerve Stimulation and Percutaneous or Implantable Tibial Nerve Stimulation for Urinary and Fecal Incontinence; Urinary Retention Previously Titled: Sacral Nerve Stimulation and Percutaneous Tibial Nerve Stimulation for Urinary and Fecal Incontinence, Urinary Retention

Revised

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CD-044162-23-CPN43701

Medical Policy & Clinical GuidelinesMedicare AdvantageNovember 21, 2023

Medical Policies and Clinical Utilization Management Guidelines update for May 2023

The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised to support clinical coding edits. Note, several policies and guidelines were revised to provide clarification only and are not included. Existing precertification requirements have not changed.

Please share this notice with other providers in your practice and office staff.

To view a guideline, visit Medicare Advantage Providers | Anthem.com and select Change State. Then select your state > Providers > Policies, Guidelines & Manuals.

Notes/updates

Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive.

  • MED.00004 – Noninvasive Imaging Technologies for the Evaluation of Skin Lesions; Previously Titled: Technologies for the Evaluation of Skin Lesions (including Dermatoscopy, Epiluminescence Microscopy, Videomicroscopy and Ultrasonography):
    • Revised title
    • Added additional technologies to Investigational & Not Medically Necessary section.
  • SURG.00161 – Nanoparticle-Mediated Thermal Ablation:
    • Nanoparticle-mediated thermal ablation is considered Investigational & Not Medically Necessary for all indications
  • CG-ANC-06 – Ambulance Services: Ground; Non-Emergent:
    • Revised Medically Necessary and Not Medically Necessary statements regarding mileage.
    • Revised Not Medically Necessary statement to remove list of non-covered indications.
  • CG-LAB-29 – Gamma Glutamyl Transferase Testing:
    • Outlines the Medically Necessary and Not Medically Necessary criteria for laboratory testing of gamma glutamyl transferase (GGT) in blood.
  • CG-LAB-30 – Outpatient Laboratory-based Blood Glucose Testing:
    • Outlines the Medically Necessary and Not Medically Necessary criteria for laboratory testing to determine blood glucose concentration.
  • CG-SURG-95 – Sacral Nerve Stimulation and Percutaneous or Implantable Tibial Nerve Stimulation for Urinary and Fecal Incontinence; Urinary Retention; Previously Titled: Sacral Nerve Stimulation and Percutaneous Tibial Nerve Stimulation for Urinary and Fecal Incontinence, Urinary Retention:
    • Revised title
    • Added Medically Necessary criteria for temporary SNS for urinary and fecal conditions.
    • Reformatted Medically Necessary criteria for permanent SNS for urinary and fecal conditions.
    • Revised the Clinical Indications section IV for percutaneous or implantable tibial nerve stimulation (PTNS) to include implantable devices.

Medical Policies

On May 11, 2023, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem Blue Cross and Blue Shield (Anthem). These medical policies take effect December 27, 2023.

Publish date

Medical Policy number

Medical Policy title

New or revised

5/25/2023

GENE.00052

Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling

Revised

6/28/2023

*MED.00004

Noninvasive Imaging Technologies for the Evaluation of Skin Lesions Previously Titled: Technologies for the Evaluation of Skin Lesions (including Dermatoscopy, Epiluminescence Microscopy, Videomicroscopy and Ultrasonography)

Revised

7/18/2023

MED.00135

Gene Therapy for Hemophilia

Revised

5/25/2023

SURG.00121

Transcatheter Heart Valve Procedures

Revised

6/28/2023

*SURG.00161

Nanoparticle-Mediated Thermal Ablation

New

6/28/2023

TRANS.00025

Laboratory Testing as an Aid in the Diagnosis of Heart Transplant Rejection

Revised

Clinical UM Guidelines

On May 11, 2023, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Medicare members on June 22, 2023. These guidelines take effect December 27, 2023.

Publish date

Clinical UM Guideline number

Clinical UM Guideline title

New or revised

6/28/2023

*CG-ANC-06

Ambulance Services: Ground; Non-Emergent

Revised

6/28/2023

CG-DME-31

Powered Wheeled Mobility Devices

Revised

6/28/2023

CG-DME-36

Pediatric Gait Trainers

Revised

6/28/2023

CG-DME-42

Continuous Glucose Monitoring Devices and External Insulin Infusion Pumps

Revised

6/28/2023

CG-GENE-16

BRCA Genetic Testing

Revised

6/28/2023

CG-GENE-22

Gene Expression Profiling for Managing Breast Cancer Treatment

Revised

5/25/2023

CG-LAB-22

Nucleic Acid Amplification Tests Using Algorithmic Analysis for the Diagnosis of Vaginitis Previously Titled: Nucleic Acid Amplification Tests Using Algorithmic Analysis for the Diagnosis of Bacterial Vaginosis

Revised

6/28/2023

CG-LAB-25

Outpatient Glycated Hemoglobin and Protein Testing

Revised

6/28/2023

*CG-LAB-29

Gamma Glutamyl Transferase Testing

New

6/28/2023

*CG-LAB-30

Outpatient Laboratory-based Blood Glucose Testing

New

6/28/2023

CG-MED-59

Upper Gastrointestinal Endoscopy in Adults

Revised

6/28/2023

CG-MED-66

Cryopreservation of Oocytes or Ovarian Tissue

Revised

6/28/2023

CG-SURG-101

Ablative Techniques as a Treatment for Barrett's Esophagus

Revised

5/25/2023

CG-SURG-115

Mechanical Embolectomy for Treatment of Stroke

Revised

6/28/2023

CG-SURG-61

Cryosurgical, Radiofrequency or Laser Ablation to Treat Solid Tumors Outside the Liver

Revised

6/28/2023

CG-SURG-78

Locoregional Techniques for Treating Primary and Metastatic Liver Malignancies Previously Titled: Locoregional and Surgical Techniques for Treating Primary and Metastatic Liver Malignancies

Revised

6/22/2023

CG-SURG-81

Cochlear Implants and Auditory Brainstem Implants

Revised

6/28/2023

*CG-SURG-95

Sacral Nerve Stimulation and Percutaneous or Implantable Tibial Nerve Stimulation for Urinary and Fecal Incontinence; Urinary Retention Previously Titled: Sacral Nerve Stimulation and Percutaneous Tibial Nerve Stimulation for Urinary and Fecal Incontinence, Urinary Retention

Revised

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-043577-23-CPN42042

Medical Policy & Clinical GuidelinesMedicare AdvantageDecember 1, 2023

Glucagon-Like Peptide-1 prior authorization changes

Anthem Blue Cross and Blue Shield (Anthem) wants to help ensure that members have access to medications with evidence to improve health and promote evidence-based, clinically appropriate use that align with FDA prescribing guidelines.

While Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists have gained popularity because of their weight loss effects, they are currently FDA-approved for diabetes only.

Wegovy® and Saxenda® are FDA-approved for weight loss only and not for treatment of diabetes. For the most part, our member benefits specifically exclude weight loss drugs, yet GLP-1 Receptor Agonists approved only for diabetes are being used off-label for weight loss and contributing to clinically inappropriate use. Compliance with prescribing guidelines is a requirement of Anthem network participation.

Beginning January 1, 2024, we will require verification of diagnosis of diabetes for Medicare members.

GLP-1 Agents (Adlyxin, Bydureon, Byetta, Ozempic, Rybelsus, Trulicity, Victoza) requests may be approved based on the following criteria:

  • Individual has a diagnosis of type 2 diabetes; AND
  • Written documentation has been provided that diagnosis has been verified by history of:
    • Hemoglobin A1c (A1C) greater than or equal to 6.5%; OR
    • Fasting Plasma Glucose (FPG) greater than or equal to 126 mg/dl (after fasting for at least 8 hours); OR
    • Two-hour plasma glucose greater than or equal to 200mg/dl as part of an oral glucose tolerance test (75g oral glucose after fasting for at least 8 hours); OR
    • Symptoms of hyperglycemia (including polyuria, polydipsia, polyphagia) or hyperglycemic crisis and a random plasma glucose greater than or equal to 200 mg/dl; AND
    • Glucagon-like peptide-1 (GLP-1) receptor agonist may not be approved for the following:
      • Weight loss {CMS exclusion}

You can access our drug lists and formulary policies by visiting Pharmacy Information for Providers | Anthem.com. Scroll down to Drug List Management and select Drug List Selection (anthem.com). Here you will be able to search for the policies based on the member’s health plan.

If you have questions, please contact Provider Services.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-043752-23-CPN42761

Medical Policy & Clinical GuidelinesMedicaidNovember 7, 2023

Carelon Medical Benefits Management, Inc. updates

Effective April 1, 2024, Anthem Blue Cross and Blue Shield Healthcare Solutions will transition to the following Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guidelines for medical necessity/clinical appropriateness reviews for requested interventions:

  • Cardiology Guidelines:
    • Cardiac Resynchronization Therapy
    • Endovascular Revascularization
    • Implantable Cardioverter Defibrillators
    • Permanent Implantable Pacemakers
  • Genetic Testing Guidelines:
    • Carrier Screening in the Prenatal Setting and Preimplantation Genetic Testing
    • Cell-free DNA Testing for the Management of Cancer
    • Chromosomal Microarray Analysis 
    • Genetic Testing for Inherited Conditions
    • Hereditary Cancer Testing
    • Pharmacogenomic Testing
    • Polygenic Risk Scores
    • Prenatal Testing using cell-free DNA
    • Somatic Tumor Testing
    • Whole Exome Sequencing and Whole Genome Sequencing

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CD-041989-23-CPN41238

Medical Policy & Clinical GuidelinesMedicare AdvantageNovember 6, 2023

Carelon Medical Benefits Management, Inc. updates

Effective April 1, 2024, Anthem Blue Cross and Blue Shield will transition to the following Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guidelines for medical necessity /clinical appropriateness reviews for requested interventions:

  • Cardiology Guidelines:
    • Cardiac Resynchronization Therapy
    • Endovascular Revascularization
    • Implantable Cardioverter Defibrillators
    • Permanent Implantable Pacemakers
  • Genetic Testing Guidelines:
    • Carrier Screening in the Prenatal Setting and Preimplantation Genetic Testing
    • Cell-free DNA Testing for the Management of Cancer
    • Chromosomal Microarray Analysis
    • Genetic Testing for Inherited Conditions
    • Hereditary Cancer Testing
    • Pharmacogenomic Testing
    • Polygenic Risk Scores
    • Prenatal Testing using cell-free DNA
    • Somatic Tumor Testing
    • Whole Exome Sequencing and Whole Genome Sequencing

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CR-041962-23-CPN41241

Medical Policy & Clinical GuidelinesCommercialOctober 27, 2023

Transition to Carelon Medical Benefits Management, Inc. Genetic Testing Guidelines

Effective April 1, 2024, Anthem Blue Cross and Blue Shield will transition to the following Carelon Medical Benefits Management, Inc.* Genetic Testing guidelines to perform medical necessity/clinical appropriateness reviews for requested genetic tests. Applicable CPT® codes lists are included in each guideline linked below:

Prior authorization requirements remain the same. The requested services received on or after March 30, 2024, will be reviewed with the new Clinical Criteria.

As a reminder, ordering and servicing providers may submit prior authorization requests to Carelon Medical Benefits Management using the following:

  • Carelon Medical Benefits Management ProviderPortalSM directly at providerportal.com. Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.

If you have questions related to guidelines, please contact Carelon Medical Benefits Management via email at MedicalBenefitsManagement.guidelines@Carelon.com. Additionally, you may access and download a copy of the current and upcoming guidelines here.

*Carelon Medical Benefits Management, Inc. is an independent company providing administrative support services on behalf of the health plan.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-038769-23-CPN38533

Medical Policy & Clinical GuidelinesMedicaidOctober 27, 2023

InterQual 2023 - October updates

Effective February 20, 2024, Anthem Blue Cross and Blue Shield Healthcare Solutions (Anthem) will transition to the InterQual® 2023 criteria, to include updates from October 2023.

InterQual criteria used by this market:

  • Long-term Care Criteria
  • Rehabilitation Criteria
  • Subacute & SNF (Skilled Nursing Facility) Criteria

If you have questions, please contact Provider Services at 844-396-2330.

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CD-041308-23-CPN40829

Prior AuthorizationMedicare AdvantageNovember 15, 2023

Prior authorization requirement changes effective May 1, 2024 

UPDATE: This article was originally published as being effective March 1, 2024. The effective date has been delayed to May 1, 2024.

Effective May 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross and Blue Shield for Medicare members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims.

Prior authorization requirements will be added for the following code(s):

Code

Description

Q4272

Esano a, per square centimeter

Q4273

Esano aaa, per square centimeter

Q4274

Esano ac, per square centimeter

Q4275

Esano aca, per square centimeter

Q4276

Orion, per square centimeter

Q4277

Woundplus membrane or e-graft, per square centimeter

Q4278

Epieffect, per square centimeter

Q4280

Xcell amnio matrix, per square centimeter

Q4281

Barrera sl or barrera dl, per square centimeter

Q4282

Cygnus dual, per square centimeter

Q4283

Biovance tri-layer or biovance 3l, per square centimeter

Q4284

Dermabind sl, per square centimeter

Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call the number on the back of their patient’s member ID card .for assistance with PA requirements.

UM AROW #: A2023M0417

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-044198-23-CPN43849, CPN-CRMMP-049296-24

Prior AuthorizationMedicare AdvantageNovember 15, 2023

Prior authorization requirement changes effective May 1, 2024 

UPDATE: This article was originally published as being effective March 1, 2024. The effective date has been delayed to May 1, 2024.

Effective May 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross and Blue Shield for Medicare members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. 

Prior authorization requirements will be added for the following code(s):

Code

Description

0738T

Treatment planning for magnetic field induction ablation of malignant prostate tissue, using data from previously performed magnetic resonance imaging (MRI) examination

0739T

Ablation of malignant prostate tissue by magnetic field induction, including all intraprocedural, transperineal needle/catheter placement for nanoparticle installation and int

Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call the number on the back of their patient’s member ID card .for assistance with PA requirements.

UM AROW #: A2023M0443

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-044235-23-CPN43832, CPN-CRMMP-049296-24

Prior AuthorizationMedicare AdvantageNovember 9, 2023

Prior authorization requirement changes effective March 1, 2024 

Effective March 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medicare members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims.

Prior authorization requirements will be added for the following code(s):

Code

Description

0239U

Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free DNA, analysis of 311 or more genes, interrogation for sequence variants, including substitutions, ins

0388U

Oncology (non-small cell lung cancer), next-generation sequencing with identification of single nucleotide variants, copy number variants, insertions and deletions, and struct

0392U

Drug metabolism (depression, anxiety, attention deficit hyperactivity disorder [ADHD]), gene-drug interactions, variant analysis of 16 genes, including deletion/duplication an

0397U

Oncology (non-small cell lung cancer), cell-free DNA from plasma, targeted sequence analysis of at least 109 genes, including sequence variants, substitutions, insertions, del

0400U

Obstetrics (expanded carrier screening), 145 genes by nextgeneration sequencing, fragment analysis and multiplex ligationdependent probe amplification, DNA, reported as carrie

0401U

Cardiology (coronary heart disease [CAD]), 9 genes (12 variants), targeted variant genotyping, blood, saliva, or buccal swab, algorithm reported as a genetic risk score for a

Not all PA requirements are listed here. Detailed PA requirements are available to providers on providers.anthem.com/nv on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call Provider Services at 844-396-2330 for assistance with PA requirements.

UM AROW #: A2023M0444

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CR-044228-23-CPN43850

Prior AuthorizationMedicare AdvantageNovember 8, 2023

Prior authorization requirement changes effective May 1, 2024 

UPDATE: This article was originally published as being effective March 1, 2024. The effective date has been delayed to May 1, 2024.

Effective May 1, 2024, prior authorization (PA) requirements will change for the following code(s).  The medical code(s) listed below will require PA for Anthem Blue Cross and Blue Shield members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. 

Non-compliance with new requirements may result in denied claims.

Prior authorization requirements will be added for the following code(s):

Code

Description

E0761

Non-Thermal Pulsed High Frequency Radiowaves, High Peak Power Electrom

Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call the number on the back of their patient’s member ID card for Provider Services.

UM AROW #: A2023M0415

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-044184-23-CPN43845, CPN-CRMMP-049296-24

Prior AuthorizationMedicare AdvantageOctober 31, 2023

Prior authorization requirement changes effective March 1, 2024 

Effective March 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross and Blue Shield for Medicare members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage.

Non-compliance with new requirements may result in denied claims.

Prior authorization requirements will be added for the following code(s):

Code

Description

33275

Transcatheter removal of permanent leadless pacemaker, right ventricular

33274

Transcatheter insertion or replacement of permanent leadless pacemaker, right ventricular, including imaging guidance (such as fluoroscopy, venous ultrasound, ventriculography, femoral venography) and device evaluation (such as interrogation or programming), when performed

Not all PA requirements are listed here. Detailed PA requirements are available to providers by visiting Medicare Advantage Providers | Anthem.com > Providers > Claims> Prior Authorization, or for contracted providers by accessing Availity.com. Providers may also call number on the back of their patient’s member ID card for Provider Service for assistance with PA requirements.

UM AROW 4290

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-042748-23-CPN41430

Products & ProgramsCommercialDecember 1, 2023

Introducing the High Performing Provider designation

Anthem Blue Cross and Blue Shield (Anthem) is excited to announce a new High Performing Provider (HPP) designation to care providers meeting certain cost and quality metrics. Through this new designation, Anthem is expanding our consumer tools and content to assist members in making more informed and personalized healthcare decisions. Initially, the designation will focus on certain types of professional providers, but it may be broadened to include other care provider types in the future.

The High Performing Provider designation will launch on January 1, 2024.

Anthem may highlight HPPs in various ways, including, but not limited to:

  • Special opportunities to participate in product offerings.
  • When members contact Anthem with requests for referral options.
  • Placing a designation in Anthem’s Care and Cost Finder. This would be in addition to Anthem’s existing tool in Care and Cost Finder called Personalized Match that provides Anthem members with the option to search for in-network care providers through a specialized sorting tool that considers certain cost and quality metrics, as well.

For more information on the HPP designation, you can view the designation methodology, or to know if your practice will receive the designation, send an email to HPPdesignation@anthem.com.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-045688-23-CPN44770, MULTI-BCBS-CM-045690-23-CPN44770

ATTACHMENTS (available on web): designation methodology (pdf - 0.15mb)

Federal Employee Program (FEP)CommercialDecember 1, 2023

Federal Employee Program updates member ID cards

The Federal Employee Program® (FEP) will now be issuing ID cards at the member level. These cards will be issued based on the member’s plan coverage.

To implement this change, FEP is sending updated member ID cards in the fall of 2023 and early 2024.

Members who have not received their new ID card yet can continue to use their existing ID cards until the new ID card is received. For further information regarding our new Member ID cards, contact the FEP Customer Service number on the back of the member’s ID card.

Also new for 2024

Starting January 1, 2024, FEP will offer a new prescription drug benefit called FEP Medicare Prescription Drug Program (MPDP). MPDP is an optional prescription drug benefit available for members who are Medicare eligible, and part of the member’s plan coverage.

For members enrolled in MPDP, their new ID card will display their MPDP ID number. Do not confuse this with the existing Member ID card. You will still need to use the Member ID for claims submissions. Make copies of all ID cards for your records.

Please note members can disenroll from or enroll in MPDP later, and their information could change.

Below is a sample of the new Member ID card with MPDP enrollment.


The following instructions still apply when submitting claims:

  • Use a valid member ID number.
  • Include the patient’s first and last name.
  • Name the health plan policy owner (insured) who is responsible for the policy.

For further information regarding our new Member ID cards or MPDP, contact the FEP Customer Service number on the back of the member’s ID card.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-044861-23

Federal Employee Program (FEP)Medicare AdvantageDecember 1, 2023

2024 Federal Employee Program Benefit information available online

To view the 2024 benefits and changes for the Federal Employee Program® (FEP), go to Fepblue.org and select Tools and Resources, then select Brochure and Resources. Here you will find the Service Benefit Plan Brochure, Benefit Plan Summaries, and Quick Reference Guides on information for 2024. If you have questions, contact FEP customer service at

CO – 800-852-5957

CT – 800-438-5356

GA – 800-282-2473

IN – 800-382-5520

KY – 800-456-3967

ME – 800-722-0203

MO – 800-392-8043

NV – 800-727-4060

NH – 800-852-3316

OH – 800-451-7602

VA – 800-552-6989

WI – 800-242-9635.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-043908-23-CPN43800

PharmacyCommercialDecember 1, 2023

CarelonRx, Inc. Mail will change to CarelonRx Pharmacy on January 1, 2024

CarelonRx mail service pharmacy will change to CarelonRx Pharmacy on January 1, 2024.

This pharmacy change does not affect the way CarelonRx works with care providers. There are no changes to the prior authorization process, how claims are processed, or level of support.

This change does not impact your patients’ benefits, coverage, or how their medications are filled.

When e-prescribing orders to the mail service pharmacy:

  • Prescribers will need to choose CarelonRx Pharmacy, not CarelonRx Mail, if searching by name.
  • If searching by NPI (National Provider Identifier), the NPI is changing to 1568179489.

We are taking steps to ensure a smooth transition to our new home delivery pharmacy for your patients:

  • Patients will receive a letter to alert them of their new pharmacy.
  • If a patient has refills left, we will move them to CarelonRx Pharmacy, and we’ll also transfer auto refills.
  • If a patient doesn’t have any refills left of their medication(s), CarelonRx Pharmacy will contact you to obtain a new prescription.
  • If a patient is taking a controlled substance, CarelonRx Pharmacy will contact you to obtain a new prescription.
  • All prior authorizations will be transitioned to CarelonRx Pharmacy.

CarelonRx Pharmacy will deliver an enhanced, digital-first solution to your patients to improve adherence and lower costs, while removing barriers associated with traditional retail and mail order pharmacy models. Some highlights include:

  • 24/7 text or chat (digitally) directly with our pharmacists at any time.
  • Enhanced end-to-end order status tracking from prescription order to delivery.
  • Acceptance of coupons; auto apply manufactured discounts (e-voucher), if applicable.*
  • Free delivery of their 90-day supply, directly to a patient’s door.

* Not available for Medicare or Medicaid patients.

CarelonRx, Inc. is an independent company providing pharmacy benefit management services on behalf of the health plan.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-045616-23-CPN45533

PharmacyCommercialNovember 1, 2023

Pharmacy information available on our provider website

Visit the Drug Lists page on our provider website at https://www.anthem.com/ms/pharmacyinformation/home.html for more information about:

  • Copayment/coinsurance requirements and their applicable drug classes.
  • Drug lists and changes.
  • Prior authorization criteria.
  • Procedures for generic substitution.
  • Therapeutic interchange.
  • Step therapy or other management methods subject to prescribing decisions.
  • Any other requirements, restrictions, or limitations that apply to using certain drugs.

The commercial and exchange drug lists are posted to the website quarterly on the first day of the month in January, April, July, and October.

To locate the exchange, select Formulary and Pharmacy Information, and scroll down to Select Drug Lists. This drug list is also reviewed and updated regularly as needed.

Federal Employee Program pharmacy updates and other pharmacy related information may be accessed at www.fepblue.org > Pharmacy Benefits.

MULTI-BCBS-CM-018448-23, MULTI-BCBS-CM-041071-23-CPN41054, MULTI-BCBS-CM-044369-23-CPN44369

PharmacyMedicare AdvantageOctober 26, 2023

Notification of specialty pharmacy medical step therapy updates

Effective for dates of service on and after December 1, 2023, updated step criteria for Iron Agents found in Clinical Criteria document CC-0182 will be implemented. The preferred product list is being expanded. Please refer to the Clinical Criteria page for more information.

Clinical UM Guidelines are publicly available on the care provider website. Visit the Clinical Criteria page to search for specific criteria.

Clinical UM Guidelines

Preferred drug(s)

Nonpreferred drug(s)

CC-0182

Feraheme (ferumoxytol)

Ferrlecit (sodium ferric gluconate/sucrose complex)

Infed (iron dextran)

Venofer (iron sucrose)

Injectafer (ferric carboxymaltose)

Monoferric (ferric derisomaltose)

We’re committed to active involvement with our care provider partners and going beyond the contract to create a real impact on the health of our communities.

MULTI-BCBS-CR-038913-23-CPN38505

Quality ManagementMedicaidNovember 20, 2023

HEDIS measurement year 2023 documentation for Transitions of Care (TRC)

Measure description

The percentage of discharges for members 18 years of age and older who had each of the following:

  • Notification of inpatient admission (can only be captured through medical record review)
  • Receipt of discharge information (can only be captured through medical record review)
  • Patient engagement
  • Medication reconciliation post-discharge

What we are looking for in care provider records:

  • Notification of inpatient admission — documentation in the outpatient medical record must include evidence of receipt for notification of inpatient admission on the day of admission through two days after the admission (three total days) with evidence of the date when the documentation was received. Any of the following examples meet criteria:
    • Communication about admission between inpatient care providers or ER and the member’s PCP or ongoing care provider (for example, phone call, e-mail, fax, information exchange, automated alert system, shared electronic medical record, or from the member’s health plan)
    • Indication that the PCP or ongoing care provider admitted the member to the hospital
    • Indication that a specialist admitted the member to the hospital and notified the member’s PCP or ongoing care provider
    • Indication that the PCP or ongoing care provider placed orders for tests and treatments any time during the member’s inpatient stay
    • Documentation that the PCP or ongoing care provider performed a preadmission exam or received communication about a planned inpatient admission. The time frame that the preadmission exam or planned inpatient admission must be communicated is not limited to the day of admission through two days after the admission (three total days)
  • Receipt of discharge information — documentation in the outpatient medical record must include evidence of receipt of discharge information on the day of discharge through two days after the discharge (three total days) with evidence of the date when the documentation was received. Discharge information may be included in, but not limited to, a discharge summary or summary of care record, or in the structured fields in an electronic health record. At a minimum, the discharge information must include the following:
    • The practitioner responsible for the member’s care during the inpatient stay
    • Procedures or treatments provided
    • Diagnoses at discharge
    • Current medication list
    • Testing results, or documentation of pending tests or no tests pending
    • Instructions for patient care post-discharge
  • Patient engagement — documentation in the outpatient medical record must include evidence of patient engagement within 30 days after discharge. Any of the following meet criteria:
    • An outpatient visit, including office visits and home visits
    • A telephone visit
    • A synchronous telehealth visit where real-time interaction occurred between the member and care provider using audio and video communication
    • An e-visit or virtual check-in (asynchronous telehealth where two-way interaction, which was not real-time, occurred between the member and care provider)
  • Medication reconciliation — documentation in the outpatient medical record must include evidence of medication reconciliation and the date when it was performed. Medication reconciliation must be conducted by a prescribing practitioner, clinical pharmacist, physician assistant, or registered nurse. Any of the following meet criteria:
    • Documentation of the current medications with a notation that the care provider reconciled the current and discharge medications
    • Documentation of the current medications with a notation that references the discharge medications (for example, no changes in medications since discharge, same medication at discharge, discontinue all discharge medications)
    • Documentation of the member’s current medications with a notation that the discharge medications were reviewed
    • Documentation of a current medication list, a discharge medication list and notation that both lists were reviewed on the same date of service
    • Documentation of the current medications with evidence that the member was seen for post-discharge hospital follow-up with evidence of medication reconciliation or review:
      • Evidence that the member was seen for post-discharge follow-up requires documentation that indicates the care provider was aware of the member’s hospitalization or discharge
    • Documentation in the discharge summary that the discharge medications were reconciled with the most recent medication list in the outpatient medical record. There must be evidence the discharge summary was filed in the outpatient chart on the date of discharge through 30 days after discharge (31 total days).
    • Notation that no medications were prescribed or ordered upon discharge
  • Exclusions:
    • Evidence of hospice or palliative services in 2023
    • Evidence patient expired in 2023

Helpful hints:

  • Documentation of a procedure/surgery that is typically performed inpatient (such as, aortic bypass) does not indicate that the care provider is aware of the hospitalization. Documentation of post-op/surgery follow-up alone does not indicate the care provider was aware of the hospitalization or discharge. Make sure documentation references the hospitalization, admission, or inpatient stay.
  • If performing a pre-admission exam, document that it is a pre-admission exam.
  • If performing a pre-surgical, pre-operative, or surgical clearance exam, the date of the admission must be documented.
  • Implement process to receive automated alerts when a member is admitted or discharged from an inpatient facility.
  • Review discharge medications with the member.
  • Schedule post-hospital discharge following appointments and have the office call the member to remind them.
  • Document a received date for discharge summaries and notification of inpatient admissions.
  • Use the appropriate billing codes for Medication Reconciliation and Patient Engagement.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CD-038730-23-CPN38596

Quality ManagementMedicaidNovember 17, 2023

HEDIS measurement year 2023 documentation for Childhood Immunization Status (CIS)

Healthcare Effectiveness Data Information Set (HEDIS®) is a widely used set of performance measures developed and maintained by NCQA. These are used to drive improvement efforts surrounding best practices.

HEDIS 2023 documentation for Childhood Immunization Status (CIS) Measure description:

The percentage of children 2 years of age in the measurement year who had the following on or before their second birthday:

  • Four DTaP (diphtheria, tetanus, and acellular pertussis)
  • Three IPV (polio)
  • One MMR (measles, mumps, and rubella)
  • Three HiB (haemophilus influenza type B)
  • Three Hep B (hepatitis B)
  • One VZV (chicken pox)
  • Four PCV (pneumococcal conjugate)
  • One Hep A (hepatitis A)
  • Two or three RV (rotavirus)
  • Two flu (influenza)

The measure calculates a rate for each vaccine and three combination rates.

HEDIS 2023 documentation for Immunizations for Adolescents (IMA) Measure description: The percentage of adolescents 13 years of age in the measurement year who had the following:

  • One MenACWY (meningococcal)
  • One Tdap (tetanus, diphtheria toxoids and acellular pertussis)
  • Two or three HPV (human papillomavirus)

The measure calculates a rate for each vaccine and two combination rates.

HEDIS measurement year 2023 documentation for Lead Screening in Children (LSC) Measure description: The percentage of children 2 years of age who had one or more capillary or venous lead blood test for lead poisoning by their second birthday

What we are looking for in provider medical records:

  • Immunization records from birth (Department of Health immunization records are acceptable)
  • If available, newborn inpatient records documenting Hep B
  • For those immunizations not recorded on the immunization record, provide progress notes for: Immunizations administered, patient’s history of disease (chickenpox, Hep A, Hep B, measles, mumps, rubella)
  • Anaphylaxis due to the Dtap, IPV, MMR, HIB, Hep B, VZV, PCV, Hep A, RV, or Influenza vaccines
  • Encephalitis due to the Dtap vaccine
  • Diagnosis of severe combined immunodeficiency, immunodeficiency, HIV, lymphoreticular cancer, multiple myeloma, leukemia, or intussusception
  • Meningococcal vaccine with a date of service on or between the member’s 11th and 13th birthdays
  • Tdap vaccine with a date of service on or between the member’s 10th and 13th birthdays
  • At least two HPV vaccines on or between the member’s ninth and 13th birthdays and with dates of service at least 146 days apart, or at least three HPV vaccines with different dates of service on or between the member’s ninth and 13th birthdays
  • Lead testing results and date (capillary or venous) on or before the child’s second birthday
  • Evidence of hospice services in 2023
  • Evidence patient expired in 2023

Helpful hints:

  • Childhood immunizations and lead blood tests must be completed by the child’s second birthday.
  • Assess immunization needs at every clinical encounter, including sick visits and when indicated, immunize.
  • Ensure immunization records include all vaccines that were ever given, including hospitals, health departments, all former providers, include refusals, and contraindications.
  • FluMist (LAIV) vaccination (only approved for ages 2 to 49) may be used for the second vaccination; however, it must be given on the child’s second birthday to be compliant.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CD-038689-23-CPN38591

Quality ManagementMedicaidNovember 17, 2023

HEDIS medical record submission made easier with our Remote EMR Access Service

Instead of submitting medical records for the HEDIS® hybrid project, use the Remote Electronic Medical Record (EMR) Access Service provided by Anthem Blue Cross and Blue Shield Healthcare Solutions (Anthem). We offer providers the ability to grant access to your EMR system directly to pull the required documentation to aid your office in reaching compliance. Granting our team remote access to your EMR helps reduce the time and costs associated with medical record retrieval while improving efficiency and allowing your office to focus on patient care.

We have a centralized EMR team experienced with multiple EMR systems and extensively trained annually on HIPAA, EMR systems, and HEDIS measure updates. We complete medical record retrieval based on minimum necessary guidelines:

  • We only access medical records of members pulled into the HEDIS sample using specific demographic data.
  • We only retrieve the medical records that have claims evidence related to the HEDIS measures.
  • We only access the least amount of information needed for a use, disclosure, or a request.
  • We only save to file and do not physically print any PHI.

Getting started with Remote EMR Access is just one email away. Email Centralized_EMR_Team@anthem.com today. To learn more about our Remote EMR Access, view the frequently asked questions below. 

Q. How do you retrieve our medical records?

A. We access your EMR using a secure website and retrieve only the necessary documentation by printing it to an electronic file we store internally, on our secure network drives.

Q. Is this process secure?

A. Yes, we only use secure internal resources to access your EMR systems. All retrieved records are stored on Anthem secure network drives.

Q. Why does Anthem need full access to the entire medical record?

A. There are several reasons we need to look at the entire medical record of a member, including:

  • HEDIS measures can include up to a 10-year look back of a member’s information.
  • Medical record data for HEDIS compliance may come from several different areas of the EMR system, including labs, radiology, surgeries, inpatient stays, outpatient visits, and case management.
  • Compliant data may be documented or housed in a non-standard format, such as an in-office lab slip scanned into miscellaneous documents.

Q. What information do I need to submit to use your Remote EMR Access Service?

A. Email Centralized_EMR_Team@anthem.com with the following information:

Practice/facility demographic information (for example, address, National Provider ID, Taxpayer Identification Numbers, etc.)

  • EMR system information (for example, type of EMR system, required access forms, access type, etc.)
  • List of current providers/locations or a website for accessing this list.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CD-037988-23-CPN37863

Quality ManagementMedicaidNovember 13, 2023

HEDIS 2023 Electronic Clinical Data Systems (ECDS)

HEDIS® measure data is collected by one or more methods:

  • Administrative method — claims and supplemental data
  • Hybrid method — administrative and medical record data
  • Survey method — Health Outcomes Survey(HOS) & Consumer Assessment of Healthcare Providers & Systems (CAHPS®)
  • Electronic Clinical Data Systems (ECDS) — HEDIS reporting standard that leverages electronic data from multiple sources. See below.

The HEDIS Electronic Clinical Data Systems (ECDS) Reporting Standard was introduced in HEDIS 2016 (measurement year 2015) by the National Committee of Quality Assurance (NCQA) and encourages health information exchange, which is the secure sharing of patient medical information electronically. ECDS data collection is part of NCQA’s nationwide plan to capture information regarding aspects of care quality with less reliance on clinical medical record review.

There are four types of ECDS:

  1. Electronic Health Record (EHR)/Personal Health Record (PHR): Real-time, patient-centered records that make information available instantly and securely to authorized users. EHRs eligible for this category of ECDS reporting include the NCQA eMeasure certification program or any system that meets the 2015 Edition Base Electronic Health Record (EHR) definition.
  2. Health Information Exchange (HIE)/Clinical Registry: HIEs and clinical registries eligible for this reporting category include state HIEs, immunization information systems (IIS), public health agency systems, regional HIEs (RHIO), Patient-Centered Data Homes™ or other registries developed for research or to support quality improvement and patient safety initiatives. Doctors, nurses, pharmacists, other health care providers and patients can use HIEs to access and share vital medical information, with the goal of creating a complete patient record. Clinical registries can be sponsored by a government agency, nonprofit organization, health care facility or private company, and decisions regarding use of the data in the registry are the responsibility of the registry’s governing committee.
  3. Case Management System: A shared database of member information collected through a collaborative process of member assessment, care planning, care coordination or monitoring of a member’s functional status and care experience. Case management systems eligible for this category of ECDS reporting include any system developed to support the organization’s case/disease management activities, including activities performed by delegates.
  4. Administrative: Includes data from administrative claim processing systems for all services incurred (in other words, paid, suspended, pending and denied) during the period defined by each measure’s participation as well as member management files, member eligibility and enrollment files, electronic member rosters, internal audit files, and member call service databases.

Having more time to focus on patient care rather than responding to medical record requests is possible by participating in Electronic Clinical Data Systems (ECDS). We are focused on reducing administrative burdens, so you can do what you do best – care for our members. Let us help by granting EMR Direct Remote access to our EMR team.

Need more information or ready to sign up?

Please email us today at: Centralized_EMR_Team@unicare.com.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CD-041626-23-CPN41091

Quality ManagementCommercialMedicare AdvantageNovember 13, 2023

HEDIS 2023 Electronic Clinical Data Systems (ECDS)

HEDIS® measure data is collected by one or more methods:

  • Administrative method — claims and supplemental data
  • Hybrid method — administrative and medical record data
  • Survey method — Health Outcomes Survey(HOS) & Consumer Assessment of Healthcare Providers & Systems (CAHPS®)
  • Electronic Clinical Data Systems (ECDS) — HEDIS reporting standard that leverages electronic data from multiple sources. See below.

The HEDIS Electronic Clinical Data Systems (ECDS) Reporting Standard was introduced in HEDIS 2016 (measurement year 2015) by the National Committee of Quality Assurance (NCQA) and encourages health information exchange, which is the secure sharing of patient medical information electronically. ECDS data collection is part of NCQA’s nationwide plan to capture information regarding aspects of care quality with less reliance on clinical medical record review.

There are four types of ECDS:

  1. Electronic Health Record (EHR)/Personal Health Record (PHR): Real-time, patient-centered records that make information available instantly and securely to authorized users. EHRs eligible for this category of ECDS reporting include the NCQA eMeasure certification program or any system that meets the 2015 Edition Base Electronic Health Record (EHR) definition.
  2. Health Information Exchange (HIE)/Clinical Registry: HIEs and clinical registries eligible for this reporting category include state HIEs, immunization information systems (IIS), public health agency systems, regional HIEs (RHIO), Patient-Centered Data Homes™ or other registries developed for research or to support quality improvement and patient safety initiatives. Doctors, nurses, pharmacists, other health care providers and patients can use HIEs to access and share vital medical information, with the goal of creating a complete patient record. Clinical registries can be sponsored by a government agency, nonprofit organization, health care facility or private company, and decisions regarding use of the data in the registry are the responsibility of the registry’s governing committee.
  3. Case Management System: A shared database of member information collected through a collaborative process of member assessment, care planning, care coordination or monitoring of a member’s functional status and care experience. Case management systems eligible for this category of ECDS reporting include any system developed to support the organization’s case/disease management activities, including activities performed by delegates.
  4. Administrative: Includes data from administrative claim processing systems for all services incurred (in other words, paid, suspended, pending and denied) during the period defined by each measure’s participation as well as member management files, member eligibility and enrollment files, electronic member rosters, internal audit files, and member call service databases.

Having more time to focus on patient care rather than responding to medical record requests is possible by participating in Electronic Clinical Data Systems (ECDS). We are focused on reducing administrative burdens, so you can do what you do best – care for our members. Let us help by granting EMR Direct Remote access to our EMR team.

Need more information or ready to sign up?

Please email us today at: Centralized_EMR_Team@unicare.com.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-041634-23-CPN41091